glp 1 glucose dependent insulin secretion Glucagon-like peptide (GLP-1) GLP-1 is released from the

The administration does not currently approve the peptide for human use (Technically, no one is allowed to market it for consumer use, though that hasnt stopped people from purchasing research-grade peptides meant only for laboratory use on the gray market)

How ongoing care shapes GLP-1 outcomes 2x Longer on therapy Ongoing support keeps patients on GLP-1s 2x longer, maximizing long-term benefits 9+ Systems affected GLP-1s influence brain, heart, kidney, & more

Results are weak across the board Likely meaning: Substrate shortage

But before you roll up your sleeve for that vitamin B-12 injection, its worth asking: do these injections actually help with weight loss, or are they just a clever marketing hook